\
&
Contact us
\
&
Contact us
Published on | 5 years ago
ProgrammesFrom today the call for The European Innovation Procurement Awards is open for submission. The deadline of the call is 29 July at 17 hours Brussels time. As explained in the European Innovation Council 2021 work programme the awards aim to “recognise public and private buyers across Europe in their efforts to promote innovation procurement and the innovative ways the solutions are procured. It also aims to emphasise the importance of close buyer – supplier cooperation in bringing the innovative solutions to market. These awards complement other EIC initiatives aimed at supporting and fostering innovation procurement in the European Union.” This year's awards have three categories in which a winner and a runner-up will be selected:
All information related to the call can be found on the dedicated call topic pages on the funding and tender portal
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
